ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
21.394,93
-0,11%
S&P 500
6.101,24
-0,29%
Dow Jones
44.424,25
-0,32%
Euro vs US Dollar
1,05025
0,00%
Bitcoin
105.208,43
0,46%
Pepperstone
Advertisement
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. Kanada
  5. TSX

  6. Medexus Pharmaceuticals Inc (MDP) Börsenkurse

Medexus Pharmaceuticals Inc

Medexus Pharmaceuticals Inc (MDP)

Medexus Pharmaceuticals Inc
4,92
0,45
(10,07%)
Geschlossen 26 Januar 10:12PM
Verzögert um 15 Minuten

Professionelle Tools für Privatanleger.

Premium

Wichtige Statistiken und Details

Current Price
4,92
Gebot
4,92
Fragen
5,00
Volumen
296.038
4,35 Tagesbereich 5,03
1,47 52-Wochen-Bereich 5,55
Marktkapitalisierung
120,333M
Handelsende
4,47
Handelsbeginn
4,59
Letzte Trade
20
@
4.92
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
64.439
Ausgegebene Aktien
24.458.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-566,67
Gewinn pro Aktie (EPS)
-0,01
Erlöse
113,05M
Nettogewinn
-214k

Über Medexus Pharmaceuticals Inc

Sektor
Pharmaceutical Preparations
Branche
Blank Checks
Website
www.medexus.com
Hauptsitz
Bolton, Gbr
Gegründet
2013
Medexus Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the Toronto Börse with ticker MDP. The last closing price for Medexus Pharmaceuticals was $4,47. Over the last year, Medexus Pharmaceuticals shares have traded in a share price range of $ 1,47 to $ 5,55.

Medexus Pharmaceuticals currently has 24.458.000 shares in issue. The market capitalisation of Medexus Pharmaceuticals is $109,33 million. Medexus Pharmaceuticals has a price to earnings ratio (PE ratio) of -566.67.

MDP Neueste Nachrichten

Weitere Nachrichten

Medexus Pharmaceuticals Announces C$10 Million Bought-Deal Public Offering of Units

TORONTO and CHICAGO, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. ("Medexus" or the "Company") (TSX: MDP) (OTCQX: MEDXF), is pleased to announce that it has entered into an...

06 September 2023
GlobeNewswire Inc.

Medexus to Participate in the 2023 Bloom Burton & Co. Healthcare Investor Conference

TORONTO and CHICAGO, April 18, 2023 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (TSX: MDP; OTCQX: MEDXF) is pleased to announce that company management will be participating in the 2023 Bloom...

18 April 2023
GlobeNewswire Inc.

Medexus Expects Record Revenue for Fiscal Year 2023 and Provides Business Update

TORONTO and CHICAGO, April 11, 2023 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (TSX: MDP; OTCQX: MEDXF) is pleased to announce preliminary revenue estimates for the company’s fourth fiscal...

11 April 2023
GlobeNewswire Inc.

Medexus Announces New License Deal for Topical Terbinafine

TORONTO and CHICAGO, March 22, 2023 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (TSX: MDP; OTCQX: MEDXF) is pleased to announce that the company has secured Canadian rights to commercialize...

22 März 2023
GlobeNewswire Inc.

Medexus Announces US$58.5 million in New Credit Facilities

TORONTO and CHICAGO, March 08, 2023 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (TSX: MDP; TSX: MDP.DB; OTCQX: MEDXF) today entered into a new senior secured credit agreement agented by BMO. The...

08 März 2023
GlobeNewswire Inc.

Medexus to Participate in 35th Annual Roth Conference

TORONTO and CHICAGO, March 06, 2023 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (TSX: MDP; OTCQX: MEDXF) is pleased to announce that company management will be participating in the 35th Annual...

06 März 2023
GlobeNewswire Inc.

Medexus Announces Another Record Quarter with Fiscal Q3 2023 Revenue of US$28.7 Million, a 35% Increase Over Fiscal Q3 2022

Results reflect growth across all leading prescription products, demonstrating continued track record of strong overall performance Management to host conference call at 8:00 AM Eastern Time on...

08 Februar 2023
GlobeNewswire Inc.

Medexus Welcomes Two New Board Members

Harmony P. Garges MD MPH and Menassie Taddese MBA appointed to Medexus’s board of directors Appointments bolster Medexus board’s medical and financial expertise, particularly in the United States...

06 Februar 2023
GlobeNewswire Inc.

Medexus Secures Public Reimbursement for Cuvposa® in Quebec

TORONTO and CHICAGO, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (Medexus) (TSX: MDP) (OTCQX: MEDXF) wishes to inform investors that the company has reached an agreement with the...

01 Februar 2023
GlobeNewswire Inc.

Medexus Schedules Third Fiscal Quarter 2023 Conference Call

TORONTO and CHICAGO, Jan. 31, 2023 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (Medexus) (TSX: MDP) (OTCQX: MEDXF) plans to host a conference call at 8:00 am Eastern Time on Thursday...

31 Januar 2023
GlobeNewswire Inc.
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.449.821428571434.485.553.852251404.56970434CS
41.5144.28152492673.415.553.231210894.25012079CS
122.54106.7226890762.385.551.72644393.57153288CS
262.71122.6244343892.215.551.72414003.25417863CS
522.47100.8163265312.455.551.47451862.4809647CS
1562.2684.9624060152.665.550.88394192.21917777CS
260-2.46-33.33333333337.387.90.88401522.5212849CS

MDP - Frequently Asked Questions (FAQ)

What is the current Medexus Pharmaceuticals share price?
The current share price of Medexus Pharmaceuticals is $ 4,92
How many Medexus Pharmaceuticals shares are in issue?
Medexus Pharmaceuticals has 24.458.000 shares in issue
What is the market cap of Medexus Pharmaceuticals?
The market capitalisation of Medexus Pharmaceuticals is CAD 109,33M
What is the 1 year trading range for Medexus Pharmaceuticals share price?
Medexus Pharmaceuticals has traded in the range of $ 1,47 to $ 5,55 during the past year
What is the PE ratio of Medexus Pharmaceuticals?
The price to earnings ratio of Medexus Pharmaceuticals is -566,67
What is the cash to sales ratio of Medexus Pharmaceuticals?
The cash to sales ratio of Medexus Pharmaceuticals is 1,07
What is the reporting currency for Medexus Pharmaceuticals?
Medexus Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Medexus Pharmaceuticals?
The latest annual turnover of Medexus Pharmaceuticals is USD 113,05M
What is the latest annual profit for Medexus Pharmaceuticals?
The latest annual profit of Medexus Pharmaceuticals is USD -214k
What is the registered address of Medexus Pharmaceuticals?
The registered address for Medexus Pharmaceuticals is 35 NIXON ROAD, UNIT 1, BOLTON, L7E 1K1
What is the Medexus Pharmaceuticals website address?
The website address for Medexus Pharmaceuticals is www.medexus.com
Which industry sector does Medexus Pharmaceuticals operate in?
Medexus Pharmaceuticals operates in the BLANK CHECKS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
DIAMStar Diamond Corporation
$ 0,04
(33,33%)
851,62k
RAY.BStingray Group Inc
$ 7,95
(20,64%)
3k
EDTSpectral Medical Inc
$ 0,59
(15,69%)
68,5k
FRXFennec Pharmaceuticals Inc
$ 9,00
(13,92%)
8,33k
YRBYorbeau Resources Inc
$ 0,045
(12,50%)
1,44M
GLOGlobal Atomic Corporation
$ 0,63
(-32,98%)
14,4M
APLIAppili Therapeutics Inc
$ 0,03
(-14,29%)
108k
KRNKarnalyte Resources Inc
$ 0,12
(-14,29%)
4,07k
XAMXanadu Mines Ltd
$ 0,045
(-10,00%)
12,02k
AVCNAvicanna Inc
$ 0,28
(-9,68%)
303,69k
GLOGlobal Atomic Corporation
$ 0,63
(-32,98%)
14,4M
BMOBank of Montreal
$ 144,87
(0,61%)
7,29M
ENBEnbridge Inc
$ 64,61
(0,19%)
7,26M
TDToronto Dominion Bank
$ 82,18
(-0,06%)
5,9M
BCEBCE Inc
$ 33,77
(1,17%)
5,26M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

TSX
MDP
Medexus Pharmaceuticals
BIT
S27023
Societe Generale Effekten
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten